Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$859K Buy
14,552
+3,980
+38% +$197K 0.51% 55
2021
Q3
$456K Buy
10,572
+2,420
+30% +$107K 0.28% 97
2021
Q2
$319K Sell
8,152
-3,000
-27% -$117K 0.21% 110
2021
Q1
$404K Buy
11,152
+72
+0.6% +$2.56K 0.26% 101
2020
Q4
$408K Buy
11,080
+2,801
+34% +$103K 0.26% 100
2020
Q3
$288K Sell
8,279
-3,162
-28% -$111K 0.22% 101
2020
Q2
$355K Sell
11,441
-9,506
-45% -$323K 0.3% 87
2020
Q1
$648K Buy
20,947
+7,560
+56% +$258K 0.64% 50
2019
Q4
$498K Sell
13,387
-3,362
-20% -$120K 0.41% 68
2019
Q3
$571K Sell
16,749
-51,604
-75% -$1.88M 0.58% 48
2019
Q2
$2.81M Sell
68,353
-42,960
-39% -$1.71M 1.34% 19
2019
Q1
$4.49M Sell
111,313
-25,411
-19% -$1.02M 1.75% 10
2018
Q4
$5.66M Buy
136,724
+23,404
+21% +$972K 2.63% 2
2018
Q3
$4.74M Sell
113,320
-8,990
-7% -$346K 1.85% 10
2018
Q2
$4.21M Sell
122,310
-24,063
-16% -$822K 1.61% 10
2018
Q1
$4.96M Buy
146,373
+56,867
+64% +$1.95M 2.64% 10
2017
Q4
$3.08M Buy
89,506
+46,872
+110% +$1.6M 1.08% 41
2017
Q3
$1.44M Buy
42,634
+26,761
+169% +$860K 0.52% 60
2017
Q2
$506K Buy
+15,873
New +$501K 0.2% 84

Other funds holding PFE

Grace Capital's PFE Position: Q4 2021 in Review

Grace Capital increased its Pfizer (PFE) stake by 38% in Q4 2021, buying an estimated $197K and bringing the position to 14,552 shares worth $859K. The position accounts for 0.51% of the portfolio, ranked #55.

Grace Capital first reported a position in PFE in Q2 2017 and has held it in 19 quarters since. The position peaked at $5.66M in Q4 2018. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • Grace Capital held 14,552 shares of Pfizer worth $859K as of Q4 2021.
  • Grace Capital bought 3,980 Pfizer shares in Q4 2021, an estimated $197K.
  • Pfizer made up 0.51% of Grace Capital's portfolio in Q4 2021, its #55 holding.
  • Grace Capital first reported a position in Pfizer in Q2 2017 and has held it in 19 quarters since.
  • Grace Capital's Pfizer position peaked at $5.66M in Q4 2018.
  • 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.